Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease

Ji Young Hong, Sun Hee Jang, Song Yee Kim, Kyung Soo Chung, Joo Han Song, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang, Young Ae Kang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary tuberculosis (pulmonary nontuberculous mycobacterial disease: 13.80, tuberculosis: 5.85, p < 0.001). A multivariate logistic regression analysis performed in this study showed that Mycobacterium abscessus (OR 9.97, 95% CI: 1.58, 62.80; p = 0.014) and active phase of pulmonary nontuberculous mycobacterial disease (OR 12.18, 95% CI: 1.07, 138.36, p = 0.044) were found to be risk factors for serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease. The serum CA 19-9 levels showed a tendency to decrease during successful treatment of pulmonary nontuberculous mycobacterial disease but not in pulmonary tuberculosis. These findings suggest that CA 19-9 may be a useful marker for monitoring therapeutic responses in pulmonary nontuberculous mycobacterial disease, although it is not pulmonary nontuberculous mycobacterial disease-specific marker.

Original languageEnglish
Pages (from-to)26-32
Number of pages7
JournalBrazilian Journal of Infectious Diseases
Volume20
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Lung
Serum
Pulmonary Tuberculosis
Mycobacterium
Tuberculosis
Logistic Models
Regression Analysis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Hong, Ji Young ; Jang, Sun Hee ; Kim, Song Yee ; Chung, Kyung Soo ; Song, Joo Han ; Park, Moo Suk ; Kim, Young Sam ; Kim, Se Kyu ; Chang, Joon ; Kang, Young Ae. / Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease. In: Brazilian Journal of Infectious Diseases. 2016 ; Vol. 20, No. 1. pp. 26-32.
@article{41624874819f4a28bc1d42b116618c1f,
title = "Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease",
abstract = "Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary tuberculosis (pulmonary nontuberculous mycobacterial disease: 13.80, tuberculosis: 5.85, p < 0.001). A multivariate logistic regression analysis performed in this study showed that Mycobacterium abscessus (OR 9.97, 95{\%} CI: 1.58, 62.80; p = 0.014) and active phase of pulmonary nontuberculous mycobacterial disease (OR 12.18, 95{\%} CI: 1.07, 138.36, p = 0.044) were found to be risk factors for serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease. The serum CA 19-9 levels showed a tendency to decrease during successful treatment of pulmonary nontuberculous mycobacterial disease but not in pulmonary tuberculosis. These findings suggest that CA 19-9 may be a useful marker for monitoring therapeutic responses in pulmonary nontuberculous mycobacterial disease, although it is not pulmonary nontuberculous mycobacterial disease-specific marker.",
author = "Hong, {Ji Young} and Jang, {Sun Hee} and Kim, {Song Yee} and Chung, {Kyung Soo} and Song, {Joo Han} and Park, {Moo Suk} and Kim, {Young Sam} and Kim, {Se Kyu} and Joon Chang and Kang, {Young Ae}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.bjid.2015.09.005",
language = "English",
volume = "20",
pages = "26--32",
journal = "Brazilian Journal of Infectious Diseases",
issn = "1413-8670",
publisher = "Elsevier Editora Ltda",
number = "1",

}

Hong, JY, Jang, SH, Kim, SY, Chung, KS, Song, JH, Park, MS, Kim, YS, Kim, SK, Chang, J & Kang, YA 2016, 'Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease', Brazilian Journal of Infectious Diseases, vol. 20, no. 1, pp. 26-32. https://doi.org/10.1016/j.bjid.2015.09.005

Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease. / Hong, Ji Young; Jang, Sun Hee; Kim, Song Yee; Chung, Kyung Soo; Song, Joo Han; Park, Moo Suk; Kim, Young Sam; Kim, Se Kyu; Chang, Joon; Kang, Young Ae.

In: Brazilian Journal of Infectious Diseases, Vol. 20, No. 1, 01.01.2016, p. 26-32.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease

AU - Hong, Ji Young

AU - Jang, Sun Hee

AU - Kim, Song Yee

AU - Chung, Kyung Soo

AU - Song, Joo Han

AU - Park, Moo Suk

AU - Kim, Young Sam

AU - Kim, Se Kyu

AU - Chang, Joon

AU - Kang, Young Ae

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary tuberculosis (pulmonary nontuberculous mycobacterial disease: 13.80, tuberculosis: 5.85, p < 0.001). A multivariate logistic regression analysis performed in this study showed that Mycobacterium abscessus (OR 9.97, 95% CI: 1.58, 62.80; p = 0.014) and active phase of pulmonary nontuberculous mycobacterial disease (OR 12.18, 95% CI: 1.07, 138.36, p = 0.044) were found to be risk factors for serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease. The serum CA 19-9 levels showed a tendency to decrease during successful treatment of pulmonary nontuberculous mycobacterial disease but not in pulmonary tuberculosis. These findings suggest that CA 19-9 may be a useful marker for monitoring therapeutic responses in pulmonary nontuberculous mycobacterial disease, although it is not pulmonary nontuberculous mycobacterial disease-specific marker.

AB - Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary tuberculosis (pulmonary nontuberculous mycobacterial disease: 13.80, tuberculosis: 5.85, p < 0.001). A multivariate logistic regression analysis performed in this study showed that Mycobacterium abscessus (OR 9.97, 95% CI: 1.58, 62.80; p = 0.014) and active phase of pulmonary nontuberculous mycobacterial disease (OR 12.18, 95% CI: 1.07, 138.36, p = 0.044) were found to be risk factors for serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease. The serum CA 19-9 levels showed a tendency to decrease during successful treatment of pulmonary nontuberculous mycobacterial disease but not in pulmonary tuberculosis. These findings suggest that CA 19-9 may be a useful marker for monitoring therapeutic responses in pulmonary nontuberculous mycobacterial disease, although it is not pulmonary nontuberculous mycobacterial disease-specific marker.

UR - http://www.scopus.com/inward/record.url?scp=84957682830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957682830&partnerID=8YFLogxK

U2 - 10.1016/j.bjid.2015.09.005

DO - 10.1016/j.bjid.2015.09.005

M3 - Article

C2 - 26613892

AN - SCOPUS:84957682830

VL - 20

SP - 26

EP - 32

JO - Brazilian Journal of Infectious Diseases

JF - Brazilian Journal of Infectious Diseases

SN - 1413-8670

IS - 1

ER -